Filter by
Filter by
Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High-Risk Prostate Cancer
Published in the Red Journal, this study reported the late GI and GU toxicities of 54 patients with high-risk or unfavorable intermediate risk prostate cancer...
Proton Therapy: DynamicARC vs IMPT Treatment Plans & Case Studies
This symposium held at the 2023 National Proton Conference covers the advantages of DynamicARC proton therapy treatment, and how it is sharper, faster, and...
DynamicARC de Triomphe Part 2
A this year's NAPT 2023, IBA hosted a lunch symposium with our partners at Beaumont Health and Miami Cancer Institute. Our speakers built on last year's...
Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans-Atlantic, multicenter cross-sectional cohort study.
Survivals and local control are comparable among the four different local therapy strategies used for pediatric head and neck rhabdomyosarcoma (HNRMS) include...
The incidence of radiation-induced moyamoya among pediatric brain tumor patients who received photon radiation versus those who received proton beam therapy: a systematic review.
This systematic review compared incidence of moyamoya syndrome after receiving photon or proton cranial radiation for pediatric brain tumors. The authors found...